Source: Health Canada shortage reports · Updated Jul 29, 2026
Imipramine is in a widespread shortage in Canada. 3 of 6 reported products are affected. The latest manufacturer estimate for full recovery is Oct 2, 2026.
A tricyclic antidepressant used to treat depression.
Products affected
3 / 6
In shortage since
Feb 26, 2026
Est. full return
Oct 2, 2026
Reports on file
8
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
JAMP IMIPRAMINE
75MG · TABLET · JAMP PHARMA CORPORATION
DIN 02546361 · since Mar 12, 2026, est. end Oct 2, 2026 · Disruption of the manufacture of the drug.
Active shortage
JAMP IMIPRAMINE
25MG · TABLET · JAMP PHARMA CORPORATION
DIN 02546345 · since Mar 12, 2026, est. end Oct 2, 2026 · Disruption of the manufacture of the drug.
Active shortage
JAMP IMIPRAMINE
50MG · TABLET · JAMP PHARMA CORPORATION
DIN 02546353 · since Feb 26, 2026, est. end Oct 2, 2026 · Disruption of the manufacture of the drug.
Resolved
JAMP IMIPRAMINE
75MG · TABLET · JAMP PHARMA CORPORATION
DIN 02546361 · ended Jan 15, 2026 · Disruption of the manufacture of the drug.
Resolved
JAMP IMIPRAMINE
10MG · TABLET · JAMP PHARMA CORPORATION
DIN 02546337 · ended Jan 15, 2026 · Disruption of the manufacture of the drug.
Resolved
IMIPRAMINE
25MG · TABLET · AA PHARMA INC
DIN 00312797 · ended Mar 10, 2021 · Disruption of the manufacture of the drug.
Discontinued
IMIPRAMINE
50MG · TABLET · AA PHARMA INC
DIN 00326852
Resolved
IMIPRAMINE
50MG · TABLET · AA PHARMA INC
DIN 00326852 · ended May 27, 2016 · Disruption of the manufacture of the drug.
What's happening
Imipramine is currently affected by 3 active shortage reports filed with Health Canada by JAMP PHARMA CORPORATION.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Imipramine is classified under “ANTIDEPRESSANTS” (ATC N06AA).
Recent changes
Jul 29, 2026
Estimated end date pushed back : Aug 28, 2026 → Oct 2, 2026
Jul 29, 2026
Estimated end date pushed back : Aug 28, 2026 → Oct 2, 2026
Jul 28, 2026
Estimated end date pushed back : Aug 28, 2026 → Oct 2, 2026
Common questions
What is Imipramine used for?
A tricyclic antidepressant used to treat depression.
When will Imipramine be back in stock in Canada?
The latest manufacturer estimate is Oct 2, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Imipramine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.